CClinicalTrials.gg
CompletedNCT03516786Updated Sep 16, 2020

Quality of Recovery After Quadratus Lumborum Block for Cesarean Section.

An observational study in Postoperative Pain, sponsored by Corniche Hospital. Completed at 1 site in United Arab Emirates. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2020-09-16.

Sponsored by Corniche Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
25
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

The aim of this prospective study is to evaluate the recovery after cesarean section in patients who will receive Quadratus Lumborum Block (QLB) as a part of multimodal analgesia using Postoperative quality of recovery scale.

Read the detailed description

Several researchers had evaluated the effectiveness of QLB in controlling postoperative pain in different patient populations. In these studies, the effectiveness of the QLB was mainly assessed by postoperative pain scores and analgesia consumption, rather than adapting any of the more comprehensive recovery scales .

Postoperative quality of recovery scale (PostopQRS) is a relatively new recovery score, which was first published on 2010, and was designed to be a tool for assessment of multiple domains in recovery. In this assessment tool, recovery was defined as return to the pre-surgery base line scores or better.

The aim of this prospective study is to evaluate the recovery after cesarean section in patients who will receive Quadratus Lumborum Block QLB as a part of multimodal analgesia using Postoperative quality of recovery scale.

02

Conditions studied

  • Postoperative Pain

Browse trials for

03

In context

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.

This study's enrollment of 25 is below the median of 102 across 608 observational studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Corniche Hospital is the lead sponsor of 7 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Sampling method
Probability sample

Study population

Twenty five parturients, with American Society of Anesthesiologists (ASA) physical status II, with normal singleton pregnancy, at 37 weeks gestation or more, admitted to Corniche Hospital for elective caesarean section under spinal anesthesia

Inclusion criteria

American Society of Anesthesiologists (ASA) physical status II, normal singleton pregnancy, 37 weeks gestation or more Scheduled for elective cesarean section

Exclusion criteria

Exclusion Criteria:

  • Patients refusing spinal
  • Patients with BMI >35 kg/m2).
  • Expected difficult surgery (> 3 previous sections, abnormal placentation, prolonged surgery more than 2 hours from skin to end) and Estimated Blood Loss more than 1500).
  • Expected difficult spinal anesthesia.
  • Abnormal coagulation and other contraindications for spinal anesthesia and/or QLB
  • Patient with chronic pain.
  • Patient treated from psychosis.
  • Patients with communication, language barriers .
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
25 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. change from baseline postoperative quality of recovery score

    Domains of postoperative recovery score are : 1. The physiologic domain . 2. The nociceptive domain 3. The emotive domain . 4. Activities of daily living 5. Cognitive domain 6. Over all patients perspective domain

    Time frame: 72 hours

07

Study locations

1 site
  • Corniche Hospital
    Abu Dhabi, 3788, United Arab Emirates
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03516786
Lead sponsor
Corniche Hospital
Responsible party
Sponsor
First posted
May 4, 2018
Start date
Apr 1, 2018
Primary completion
Sep 15, 2019
Completion
Oct 1, 2019
Last update
Sep 16, 2020

Study contacts

Waleed Riad, MD
principal investigator · Corniche Hospital
Amr Maher, MD
principal investigator · Corncihe hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion